Industry Research Reports
Home > Reports > Chemical & Material > Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Chemical & Material
Published Date: 2026-03-25
Pages: 178 Pages
Report ld: 6284148
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cannabigerol Market Size(US$)
CAGR 2026-2032
8.7%
Market Size,2032
USD 292
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 177 million
Market Forecast in 2032(Value)
US$ 292 million
CAGR
8.7%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 292 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Cannabigerol, or CBG, is a non-psychoactive cannabinoid that is one of the many chemical compounds found within the cannabis plant. It’s often referred to as the “stem cell” or “mother” of all cannabinoids because it serves as the precursor for the development of other major cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD). CBG is produced in the early stages of the cannabis plant’s growth, and as the plant matures, it undergoes enzymatic changes that convert CBG into other cannabinoids, making it a relatively rare compound in mature cannabis plants.
The global CBG market is expanding explosively, with the core driving force coming from the surge in demand for non-psychoactive cannabinoids in the medical and health consumption sectors. On the application side, the medical sector (anti-inflammatory, neurodegenerative disease treatment clinical research breakthroughs) accounts for the majority of revenue (55%), while skin care products (antioxidant, anti-acne effects) and functional foods (relieving anxiety, pain) have become the fastest growing segments; on the technical side, microbial fermentation methods are accelerating the replacement of traditional planting extraction with zero THC compliance and cost advantages. Regional markets are showing differentiation: North America (especially the United States) accounts for 60% of the global share based on mature regulations, followed by Europe to accelerate the process of medical legalization, while the Asia-Pacific region is limited by policies (China only allows exports) and growth lags, but emerging countries such as Thailand and Malaysia are gradually opening up medical imports to release incremental space. Future competition will focus on large-scale production of high-purity CBG crystals (>99%) and patented delivery technologies (such as nanoemulsification to improve bioavailability), but regulatory lags (such as FDA not approving CBG as a dietary supplement) and supply chain fluctuations remain key risk points.
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Cannabigerol market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ilesol Pharmaceuticals
- Biosyyd
- Linnea
- Amyris
- Demetrix
- Avicanna (Aureus Santa Marta)
- Red Mesa Science & Refining, LLC
- Pharma Works LLC (CanniLabs)
- WeeDutch
- Creo Ingredient
- Mile High Labs
- Essentia Pura
- Vantage Hemp
- Verus Extracts
- Extract Labs
- GVB Biopharma
- Klersun, LLC
- Shenzhen Synceres
- Tauto Chem
- Hangzhou Keying Chem
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CBG Distillate
- CBG lsolate
Segment by Application
- Edibles
- Pharmaceuticals
- Cosmetics
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Cannabigerol study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cannabigerol: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cannabigerol Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 CBG Distillate
1.2.3 CBG lsolate
1.3 Market Segmentation by Application
1.3.1 Global Cannabigerol Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Edibles
1.3.3 Pharmaceuticals
1.3.4 Cosmetics
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cannabigerol Revenue Estimates and Forecasts (2021-2032)
2.2 Global Cannabigerol Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Cannabigerol Sales Estimates and Forecasts (2021-2032)
2.4 Global Cannabigerol Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Global Sales Market Share by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.5 Global Cannabigerol Production Capacity and Utilization (2021 vs 2025 vs 2032)
2.6 Production Comparison by Region: 2021 vs 2025 vs 2032
3 Competitive Landscape
3.1 Global Cannabigerol Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Cannabigerol Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 CBG Distillate: Market Share by Key Manufacturers
3.5.2 CBG lsolate: Market Share by Key Manufacturers
3.6 Global Cannabigerol Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Market Entry and Exit Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Cannabigerol Sales Performance by Type
4.1.1 Global Cannabigerol Sales Volume by Type (2021-2032)
4.1.2 Global Cannabigerol Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Cannabigerol Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Cannabigerol Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 Global Production Analysis
6.1 Global Cannabigerol Production Capacity and Utilization Rates (2021–2032)
6.2 Regional Production Dynamics and Outlook
6.2.1 Historic Production by Region (2021-2026)
6.2.2 Forecasted Production by Region (2027-2032)
6.2.3 Production Market Share by Region (2021-2032)
6.2.4 Regulatory and Trade Policy Impact on Production
6.2.5 Production Capacity Enablers and Constraints
6.3 Key Regional Production Hubs
6.3.1 North America
6.3.2 Europe
6.3.3 China
6.3.4 Japan
7 North America
7.1 North America Sales Volume and Revenue (2021-2032)
7.2 North America Key Manufacturers Sales Revenue in 2025
7.3 North America Cannabigerol Sales and Revenue by Application (2021-2032)
7.4 North America Growth Accelerators and Market Barriers
7.5 North America Cannabigerol Market Size by Country
7.5.1 North America Revenue by Country
7.5.2 North America Sales Trends by Country
7.5.3 US
7.5.4 Canada
7.5.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2021-2032)
8.2 Europe Key Manufacturers Sales Revenue in 2025
8.3 Europe Cannabigerol Sales and Revenue by Application (2021-2032)
8.4 Europe Growth Accelerators and Market Barriers
8.5 Europe Cannabigerol Market Size by Country
8.5.1 Europe Revenue by Country
8.5.2 Europe Sales Trends by Country
8.5.3 Germany
8.5.4 France
8.5.5 U.K.
8.5.6 Italy
8.5.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
9.3 Asia-Pacific Cannabigerol Sales and Revenue by Application (2021-2032)
9.4 Asia-Pacific Cannabigerol Market Size by Region
9.4.1 Asia-Pacific Revenue by Region
9.4.2 Asia-Pacific Sales Trends by Region
9.5 Asia-Pacific Growth Accelerators and Market Barriers
9.6 Southeast Asia
9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.7 China
9.8 Japan
9.9 South Korea
9.10 China Taiwan
9.11 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2021-2032)
10.2 Central and South America Key Manufacturers Sales Revenue in 2025
10.3 Central and South America Cannabigerol Sales and Revenue by Application (2021-2032)
10.4 Central and South America Investment Opportunities and Key Challenges
10.5 Central and South America Cannabigerol Market Size by Country
10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 Brazil
10.5.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
11.3 Middle East and Africa Cannabigerol Sales and Revenue by Application (2021-2032)
11.4 Middle East and Africa Investment Opportunities and Key Challenges
11.5 Middle East and Africa Cannabigerol Market Size by Country
11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
11.5.2 GCC Countries
11.5.3 Turkey
11.5.4 Egypt
11.5.5 South Africa
12 Corporate Profile
12.1 Ilesol Pharmaceuticals
12.1.1 Ilesol Pharmaceuticals Corporation Information
12.1.2 Ilesol Pharmaceuticals Business Overview
12.1.3 Ilesol Pharmaceuticals Cannabigerol Product Models, Descriptions and Specifications
12.1.4 Ilesol Pharmaceuticals Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.1.5 Ilesol Pharmaceuticals Cannabigerol Sales by Product in 2025
12.1.6 Ilesol Pharmaceuticals Cannabigerol Sales by Application in 2025
12.1.7 Ilesol Pharmaceuticals Cannabigerol Sales by Geographic Area in 2025
12.1.8 Ilesol Pharmaceuticals Cannabigerol SWOT Analysis
12.1.9 Ilesol Pharmaceuticals Recent Developments
12.2 Biosyyd
12.2.1 Biosyyd Corporation Information
12.2.2 Biosyyd Business Overview
12.2.3 Biosyyd Cannabigerol Product Models, Descriptions and Specifications
12.2.4 Biosyyd Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.2.5 Biosyyd Cannabigerol Sales by Product in 2025
12.2.6 Biosyyd Cannabigerol Sales by Application in 2025
12.2.7 Biosyyd Cannabigerol Sales by Geographic Area in 2025
12.2.8 Biosyyd Cannabigerol SWOT Analysis
12.2.9 Biosyyd Recent Developments
12.3 Linnea
12.3.1 Linnea Corporation Information
12.3.2 Linnea Business Overview
12.3.3 Linnea Cannabigerol Product Models, Descriptions and Specifications
12.3.4 Linnea Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.3.5 Linnea Cannabigerol Sales by Product in 2025
12.3.6 Linnea Cannabigerol Sales by Application in 2025
12.3.7 Linnea Cannabigerol Sales by Geographic Area in 2025
12.3.8 Linnea Cannabigerol SWOT Analysis
12.3.9 Linnea Recent Developments
12.4 Amyris
12.4.1 Amyris Corporation Information
12.4.2 Amyris Business Overview
12.4.3 Amyris Cannabigerol Product Models, Descriptions and Specifications
12.4.4 Amyris Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.4.5 Amyris Cannabigerol Sales by Product in 2025
12.4.6 Amyris Cannabigerol Sales by Application in 2025
12.4.7 Amyris Cannabigerol Sales by Geographic Area in 2025
12.4.8 Amyris Cannabigerol SWOT Analysis
12.4.9 Amyris Recent Developments
12.5 Demetrix
12.5.1 Demetrix Corporation Information
12.5.2 Demetrix Business Overview
12.5.3 Demetrix Cannabigerol Product Models, Descriptions and Specifications
12.5.4 Demetrix Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.5.5 Demetrix Cannabigerol Sales by Product in 2025
12.5.6 Demetrix Cannabigerol Sales by Application in 2025
12.5.7 Demetrix Cannabigerol Sales by Geographic Area in 2025
12.5.8 Demetrix Cannabigerol SWOT Analysis
12.5.9 Demetrix Recent Developments
12.6 Avicanna (Aureus Santa Marta)
12.6.1 Avicanna (Aureus Santa Marta) Corporation Information
12.6.2 Avicanna (Aureus Santa Marta) Business Overview
12.6.3 Avicanna (Aureus Santa Marta) Cannabigerol Product Models, Descriptions and Specifications
12.6.4 Avicanna (Aureus Santa Marta) Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.6.5 Avicanna (Aureus Santa Marta) Recent Developments
12.7 Red Mesa Science & Refining, LLC
12.7.1 Red Mesa Science & Refining, LLC Corporation Information
12.7.2 Red Mesa Science & Refining, LLC Business Overview
12.7.3 Red Mesa Science & Refining, LLC Cannabigerol Product Models, Descriptions and Specifications
12.7.4 Red Mesa Science & Refining, LLC Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.7.5 Red Mesa Science & Refining, LLC Recent Developments
12.8 Pharma Works LLC (CanniLabs)
12.8.1 Pharma Works LLC (CanniLabs) Corporation Information
12.8.2 Pharma Works LLC (CanniLabs) Business Overview
12.8.3 Pharma Works LLC (CanniLabs) Cannabigerol Product Models, Descriptions and Specifications
12.8.4 Pharma Works LLC (CanniLabs) Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.8.5 Pharma Works LLC (CanniLabs) Recent Developments
12.9 WeeDutch
12.9.1 WeeDutch Corporation Information
12.9.2 WeeDutch Business Overview
12.9.3 WeeDutch Cannabigerol Product Models, Descriptions and Specifications
12.9.4 WeeDutch Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.9.5 WeeDutch Recent Developments
12.10 Creo Ingredient
12.10.1 Creo Ingredient Corporation Information
12.10.2 Creo Ingredient Business Overview
12.10.3 Creo Ingredient Cannabigerol Product Models, Descriptions and Specifications
12.10.4 Creo Ingredient Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.10.5 Creo Ingredient Recent Developments
12.11 Mile High Labs
12.11.1 Mile High Labs Corporation Information
12.11.2 Mile High Labs Business Overview
12.11.3 Mile High Labs Cannabigerol Product Models, Descriptions and Specifications
12.11.4 Mile High Labs Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.11.5 Mile High Labs Recent Developments
12.12 Essentia Pura
12.12.1 Essentia Pura Corporation Information
12.12.2 Essentia Pura Business Overview
12.12.3 Essentia Pura Cannabigerol Product Models, Descriptions and Specifications
12.12.4 Essentia Pura Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.12.5 Essentia Pura Recent Developments
12.13 Vantage Hemp
12.13.1 Vantage Hemp Corporation Information
12.13.2 Vantage Hemp Business Overview
12.13.3 Vantage Hemp Cannabigerol Product Models, Descriptions and Specifications
12.13.4 Vantage Hemp Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.13.5 Vantage Hemp Recent Developments
12.14 Verus Extracts
12.14.1 Verus Extracts Corporation Information
12.14.2 Verus Extracts Business Overview
12.14.3 Verus Extracts Cannabigerol Product Models, Descriptions and Specifications
12.14.4 Verus Extracts Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.14.5 Verus Extracts Recent Developments
12.15 Extract Labs
12.15.1 Extract Labs Corporation Information
12.15.2 Extract Labs Business Overview
12.15.3 Extract Labs Cannabigerol Product Models, Descriptions and Specifications
12.15.4 Extract Labs Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.15.5 Extract Labs Recent Developments
12.16 GVB Biopharma
12.16.1 GVB Biopharma Corporation Information
12.16.2 GVB Biopharma Business Overview
12.16.3 GVB Biopharma Cannabigerol Product Models, Descriptions and Specifications
12.16.4 GVB Biopharma Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.16.5 GVB Biopharma Recent Developments
12.17 Klersun, LLC
12.17.1 Klersun, LLC Corporation Information
12.17.2 Klersun, LLC Business Overview
12.17.3 Klersun, LLC Cannabigerol Product Models, Descriptions and Specifications
12.17.4 Klersun, LLC Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.17.5 Klersun, LLC Recent Developments
12.18 Shenzhen Synceres
12.18.1 Shenzhen Synceres Corporation Information
12.18.2 Shenzhen Synceres Business Overview
12.18.3 Shenzhen Synceres Cannabigerol Product Models, Descriptions and Specifications
12.18.4 Shenzhen Synceres Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.18.5 Shenzhen Synceres Recent Developments
12.19 Tauto Chem
12.19.1 Tauto Chem Corporation Information
12.19.2 Tauto Chem Business Overview
12.19.3 Tauto Chem Cannabigerol Product Models, Descriptions and Specifications
12.19.4 Tauto Chem Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.19.5 Tauto Chem Recent Developments
12.20 Hangzhou Keying Chem
12.20.1 Hangzhou Keying Chem Corporation Information
12.20.2 Hangzhou Keying Chem Business Overview
12.20.3 Hangzhou Keying Chem Cannabigerol Product Models, Descriptions and Specifications
12.20.4 Hangzhou Keying Chem Cannabigerol Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.20.5 Hangzhou Keying Chem Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Cannabigerol Industry Chain
13.2 Cannabigerol Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Cannabigerol Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Cannabigerol Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Cannabigerol Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
14.4 Impact of U.S. Tariffs
15 Key Findings in the Global Cannabigerol Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cannabigerol Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Cannabigerol Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Cannabigerol Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Cannabigerol Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Table 5. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 6. Global Cannabigerol Production Growth Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Table 7. Global Cannabigerol Sales by Manufacturers (Tons), 2021-2026
Table 8. Global Cannabigerol Sales Share by Manufacturers (2021-2026)
Table 9. Global Cannabigerol Revenue by Manufacturers (US$ Million), 2021-2026
Table 10. Global Cannabigerol Revenue-Based Market Share by Manufacturers (2021-2026)
Table 11. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 12. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Cannabigerol Revenue, 2025
Table 13. Global Cannabigerol Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 14. Global Cannabigerol Average Selling Price (ASP) by Manufacturers (US$/kg), 2021-2026
Table 15. Key Manufacturers Cannabigerol Manufacturing Base and Headquarters
Table 16. Global Cannabigerol Market Concentration Ratio (CR5)
Table 17. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 18. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 19. Global Cannabigerol Sales Volume by Type (Tons), 2021-2026
Table 20. Global Cannabigerol Sales Volume by Type (Tons), 2027-2032
Table 21. Global Cannabigerol Revenue by Type (US$ Million), 2021-2026
Table 22. Global Cannabigerol Revenue by Type (US$ Million), 2027-2032
Table 23. Technical Specifications by Key Product Type
Table 24. Global Cannabigerol Sales by Application (Tons), 2021-2026
Table 25. Global Cannabigerol Sales by Application (Tons), 2027-2032
Table 26. Cannabigerol High-Growth Sectors Demand CAGR (2026-2032)
Table 27. Global Cannabigerol Revenue by Application (US$ Million), 2021-2026
Table 28. Global Cannabigerol Revenue by Application (US$ Million), 2027-2032
Table 29. Top Customers by Region
Table 30. Top Customers by Application
Table 31. Global Cannabigerol Production by Region (Tons), 2021-2026
Table 32. Global Cannabigerol Production by Region (Tons), 2027-2032
Table 33. North America Cannabigerol Growth Accelerators and Market Barriers
Table 34. North America Cannabigerol Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 35. North America Cannabigerol Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 36. Europe Cannabigerol Growth Accelerators and Market Barriers
Table 37. Europe Cannabigerol Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Europe Cannabigerol Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 39. Asia-Pacific Cannabigerol Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 40. Asia-Pacific Cannabigerol Sales (Tons) by Country (2021 vs 2025 vs 2032)
Table 41. Asia-Pacific Cannabigerol Growth Accelerators and Market Barriers
Table 42. Southeast Asia Cannabigerol Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Central and South America Cannabigerol Investment Opportunities and Key Challenges
Table 44. Central and South America Cannabigerol Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 45. Middle East and Africa Cannabigerol Investment Opportunities and Key Challenges
Table 46. Middle East and Africa Cannabigerol Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 47. Ilesol Pharmaceuticals Corporation Information
Table 48. Ilesol Pharmaceuticals Description and Major Businesses
Table 49. Ilesol Pharmaceuticals Product Models, Descriptions and Specifications
Table 50. Ilesol Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 51. Ilesol Pharmaceuticals Sales Value Proportion by Product in 2025
Table 52. Ilesol Pharmaceuticals Sales Value Proportion by Application in 2025
Table 53. Ilesol Pharmaceuticals Sales Value Proportion by Geographic Area in 2025
Table 54. Ilesol Pharmaceuticals Cannabigerol SWOT Analysis
Table 55. Ilesol Pharmaceuticals Recent Developments
Table 56. Biosyyd Corporation Information
Table 57. Biosyyd Description and Major Businesses
Table 58. Biosyyd Product Models, Descriptions and Specifications
Table 59. Biosyyd Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 60. Biosyyd Sales Value Proportion by Product in 2025
Table 61. Biosyyd Sales Value Proportion by Application in 2025
Table 62. Biosyyd Sales Value Proportion by Geographic Area in 2025
Table 63. Biosyyd Cannabigerol SWOT Analysis
Table 64. Biosyyd Recent Developments
Table 65. Linnea Corporation Information
Table 66. Linnea Description and Major Businesses
Table 67. Linnea Product Models, Descriptions and Specifications
Table 68. Linnea Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 69. Linnea Sales Value Proportion by Product in 2025
Table 70. Linnea Sales Value Proportion by Application in 2025
Table 71. Linnea Sales Value Proportion by Geographic Area in 2025
Table 72. Linnea Cannabigerol SWOT Analysis
Table 73. Linnea Recent Developments
Table 74. Amyris Corporation Information
Table 75. Amyris Description and Major Businesses
Table 76. Amyris Product Models, Descriptions and Specifications
Table 77. Amyris Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 78. Amyris Sales Value Proportion by Product in 2025
Table 79. Amyris Sales Value Proportion by Application in 2025
Table 80. Amyris Sales Value Proportion by Geographic Area in 2025
Table 81. Amyris Cannabigerol SWOT Analysis
Table 82. Amyris Recent Developments
Table 83. Demetrix Corporation Information
Table 84. Demetrix Description and Major Businesses
Table 85. Demetrix Product Models, Descriptions and Specifications
Table 86. Demetrix Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 87. Demetrix Sales Value Proportion by Product in 2025
Table 88. Demetrix Sales Value Proportion by Application in 2025
Table 89. Demetrix Sales Value Proportion by Geographic Area in 2025
Table 90. Demetrix Cannabigerol SWOT Analysis
Table 91. Demetrix Recent Developments
Table 92. Avicanna (Aureus Santa Marta) Corporation Information
Table 93. Avicanna (Aureus Santa Marta) Description and Major Businesses
Table 94. Avicanna (Aureus Santa Marta) Product Models, Descriptions and Specifications
Table 95. Avicanna (Aureus Santa Marta) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 96. Avicanna (Aureus Santa Marta) Recent Developments
Table 97. Red Mesa Science & Refining, LLC Corporation Information
Table 98. Red Mesa Science & Refining, LLC Description and Major Businesses
Table 99. Red Mesa Science & Refining, LLC Product Models, Descriptions and Specifications
Table 100. Red Mesa Science & Refining, LLC Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 101. Red Mesa Science & Refining, LLC Recent Developments
Table 102. Pharma Works LLC (CanniLabs) Corporation Information
Table 103. Pharma Works LLC (CanniLabs) Description and Major Businesses
Table 104. Pharma Works LLC (CanniLabs) Product Models, Descriptions and Specifications
Table 105. Pharma Works LLC (CanniLabs) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 106. Pharma Works LLC (CanniLabs) Recent Developments
Table 107. WeeDutch Corporation Information
Table 108. WeeDutch Description and Major Businesses
Table 109. WeeDutch Product Models, Descriptions and Specifications
Table 110. WeeDutch Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 111. WeeDutch Recent Developments
Table 112. Creo Ingredient Corporation Information
Table 113. Creo Ingredient Description and Major Businesses
Table 114. Creo Ingredient Product Models, Descriptions and Specifications
Table 115. Creo Ingredient Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 116. Creo Ingredient Recent Developments
Table 117. Mile High Labs Corporation Information
Table 118. Mile High Labs Description and Major Businesses
Table 119. Mile High Labs Product Models, Descriptions and Specifications
Table 120. Mile High Labs Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 121. Mile High Labs Recent Developments
Table 122. Essentia Pura Corporation Information
Table 123. Essentia Pura Description and Major Businesses
Table 124. Essentia Pura Product Models, Descriptions and Specifications
Table 125. Essentia Pura Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 126. Essentia Pura Recent Developments
Table 127. Vantage Hemp Corporation Information
Table 128. Vantage Hemp Description and Major Businesses
Table 129. Vantage Hemp Product Models, Descriptions and Specifications
Table 130. Vantage Hemp Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 131. Vantage Hemp Recent Developments
Table 132. Verus Extracts Corporation Information
Table 133. Verus Extracts Description and Major Businesses
Table 134. Verus Extracts Product Models, Descriptions and Specifications
Table 135. Verus Extracts Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 136. Verus Extracts Recent Developments
Table 137. Extract Labs Corporation Information
Table 138. Extract Labs Description and Major Businesses
Table 139. Extract Labs Product Models, Descriptions and Specifications
Table 140. Extract Labs Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 141. Extract Labs Recent Developments
Table 142. GVB Biopharma Corporation Information
Table 143. GVB Biopharma Description and Major Businesses
Table 144. GVB Biopharma Product Models, Descriptions and Specifications
Table 145. GVB Biopharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 146. GVB Biopharma Recent Developments
Table 147. Klersun, LLC Corporation Information
Table 148. Klersun, LLC Description and Major Businesses
Table 149. Klersun, LLC Product Models, Descriptions and Specifications
Table 150. Klersun, LLC Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 151. Klersun, LLC Recent Developments
Table 152. Shenzhen Synceres Corporation Information
Table 153. Shenzhen Synceres Description and Major Businesses
Table 154. Shenzhen Synceres Product Models, Descriptions and Specifications
Table 155. Shenzhen Synceres Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 156. Shenzhen Synceres Recent Developments
Table 157. Tauto Chem Corporation Information
Table 158. Tauto Chem Description and Major Businesses
Table 159. Tauto Chem Product Models, Descriptions and Specifications
Table 160. Tauto Chem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 161. Tauto Chem Recent Developments
Table 162. Hangzhou Keying Chem Corporation Information
Table 163. Hangzhou Keying Chem Description and Major Businesses
Table 164. Hangzhou Keying Chem Product Models, Descriptions and Specifications
Table 165. Hangzhou Keying Chem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026)
Table 166. Hangzhou Keying Chem Recent Developments
Table 167. Key Raw Materials Distribution
Table 168. Raw Materials Key Suppliers
Table 169. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 170. Milestones in Production Technology Evolution
Table 171. Distributors List
Table 172. Market Trends and Market Evolution
Table 173. Market Drivers and Opportunities
Table 174. Market Challenges, Risks, and Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Cannabigerol Product Picture
Figure 2. Global Cannabigerol Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. CBG Distillate Product Picture
Figure 4. CBG lsolate Product Picture
Figure 5. Global Cannabigerol Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Edibles
Figure 7. Pharmaceuticals
Figure 8. Cosmetics
Figure 9. Others
Figure 10. Cannabigerol Report Years Considered
Figure 11. Global Cannabigerol Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Cannabigerol Revenue (US$ Million), 2021-2032
Figure 13. Global Cannabigerol Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Global Cannabigerol Revenue-Based Market Share by Region (2021-2032)
Figure 15. Global Cannabigerol Sales (Tons), 2021-2032
Figure 16. Global Cannabigerol Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (Tons)
Figure 17. Global Cannabigerol Sales Market Share by Region (2021-2032)
Figure 18. Global Cannabigerol Capacity, Production and Utilization (Tons), 2021 vs 2025 vs 2032
Figure 19. Top 5 and Top 10 Manufacturers Cannabigerol Sales Volume Market Share in 2025
Figure 20. Global Cannabigerol Revenue-Based Market Share Ranking (2025)
Figure 21. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 22. CBG Distillate Revenue-Based Market Share by Manufacturer in 2025
Figure 23. CBG lsolate Revenue-Based Market Share by Manufacturer in 2025
Figure 24. Global Cannabigerol Sales Volume-Based Market Share by Type (2021-2032)
Figure 25. Global Cannabigerol Revenue-Based Market Share by Type (2021-2032)
Figure 26. Global Cannabigerol ASP by Type (US$/kg), 2021-2032
Figure 27. Global Cannabigerol Sales Market Share by Application (2021-2032)
Figure 28. Global Cannabigerol Revenue-Based Market Share by Application (2021-2032)
Figure 29. Global Cannabigerol ASP by Application (US$/kg), 2021-2032
Figure 30. Global Cannabigerol Capacity, Production and Utilization (Tons), 2021-2032
Figure 31. Global Cannabigerol Production Market Share by Region (2021-2032)
Figure 32. Production Capacity Enablers & Constraints
Figure 33. Cannabigerol Production Growth Rate in North America (Tons), 2021-2032
Figure 34. Cannabigerol Production Growth Rate in Europe (Tons), 2021-2032
Figure 35. Cannabigerol Production Growth Rate in China (Tons), 2021-2032
Figure 36. Cannabigerol Production Growth Rate in Japan (Tons), 2021-2032
Figure 37. North America Cannabigerol Sales YoY (Tons), 2021-2032
Figure 38. North America Cannabigerol Revenue YoY (US$ Million), 2021-2032
Figure 39. North America Top 5 Manufacturers Cannabigerol Sales Revenue (US$ Million) in 2025
Figure 40. North America Cannabigerol Sales Volume (Tons) by Application (2021-2032)
Figure 41. North America Cannabigerol Sales Revenue (US$ Million) by Application (2021-2032)
Figure 42. US Cannabigerol Revenue (US$ Million), 2021-2032
Figure 43. Canada Cannabigerol Revenue (US$ Million), 2021-2032
Figure 44. Mexico Cannabigerol Revenue (US$ Million), 2021-2032
Figure 45. Europe Cannabigerol Sales YoY (Tons), 2021-2032
Figure 46. Europe Cannabigerol Revenue YoY (US$ Million), 2021-2032
Figure 47. Europe Top 5 Manufacturers Cannabigerol Sales Revenue (US$ Million) in 2025
Figure 48. Europe Cannabigerol Sales Volume (Tons) by Application (2021-2032)
Figure 49. Europe Cannabigerol Sales Revenue (US$ Million) by Application (2021-2032)
Figure 50. Germany Cannabigerol Revenue (US$ Million), 2021-2032
Figure 51. France Cannabigerol Revenue (US$ Million), 2021-2032
Figure 52. U.K. Cannabigerol Revenue (US$ Million), 2021-2032
Figure 53. Italy Cannabigerol Revenue (US$ Million), 2021-2032
Figure 54. Russia Cannabigerol Revenue (US$ Million), 2021-2032
Figure 55. Asia-Pacific Cannabigerol Sales YoY (Tons), 2021-2032
Figure 56. Asia-Pacific Cannabigerol Revenue YoY (US$ Million), 2021-2032
Figure 57. Asia-Pacific Top 8 Manufacturers Cannabigerol Sales Revenue (US$ Million) in 2025
Figure 58. Asia-Pacific Cannabigerol Sales Volume (Tons) by Application (2021-2032)
Figure 59. Asia-Pacific Cannabigerol Sales Revenue (US$ Million) by Application (2021-2032)
Figure 60. Indonesia Cannabigerol Revenue (US$ Million), 2021-2032
Figure 61. Japan Cannabigerol Revenue (US$ Million), 2021-2032
Figure 62. South Korea Cannabigerol Revenue (US$ Million), 2021-2032
Figure 63. China Taiwan Cannabigerol Revenue (US$ Million), 2021-2032
Figure 64. India Cannabigerol Revenue (US$ Million), 2021-2032
Figure 65. Central and South America Cannabigerol Sales YoY (Tons), 2021-2032
Figure 66. Central and South America Cannabigerol Revenue YoY (US$ Million), 2021-2032
Figure 67. Central and South America Top 5 Manufacturers Cannabigerol Sales Revenue (US$ Million) in 2025
Figure 68. Central and South America Cannabigerol Sales Volume (Tons) by Application (2021-2032)
Figure 69. Central and South America Cannabigerol Sales Revenue (US$ Million) by Application (2021-2032)
Figure 70. Brazil Cannabigerol Revenue (US$ Million), 2021-2032
Figure 71. Argentina Cannabigerol Revenue (US$ Million), 2021-2032
Figure 72. Middle East, and Africa Cannabigerol Sales YoY (Tons), 2021-2032
Figure 73. Middle East and Africa Cannabigerol Revenue YoY (US$ Million), 2021-2032
Figure 74. Middle East and Africa Top 5 Manufacturers Cannabigerol Sales Revenue (US$ Million) in 2025
Figure 75. Middle East and Africa Cannabigerol Sales Volume (Tons) by Application (2021-2032)
Figure 76. Middle East and Africa Cannabigerol Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. GCC Countries Cannabigerol Revenue (US$ Million), 2021-2032
Figure 78. Turkey Cannabigerol Revenue (US$ Million), 2021-2032
Figure 79. Egypt Cannabigerol Revenue (US$ Million), 2021-2032
Figure 80. South Africa Cannabigerol Revenue (US$ Million), 2021-2032
Figure 81. Cannabigerol Industry Chain Mapping
Figure 82. Regional Cannabigerol Manufacturing Base Distribution (%)
Figure 83. Cannabigerol Production Process
Figure 84. Regional Cannabigerol Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cannabigerol market?
The top companies in the global Cannabigerol market are Ilesol Pharmaceuticals、Biosyyd、Linnea.
What is the annual compound growth rate of the global Cannabigerol market size from 2026 to 2032?
Which region is expected to have the highest market share?
What was the global market size of Cannabigerol in 2026?
What was the global market size of Cannabigerol in 2032?
Related Reports
Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cannabigerol market size was US$ 164 million in 2025 and is forecast to reach a readjusted size of US$ 292 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published Date: 2026-03-25
Pages: 107
USD 4250.00
(Single User License)
Global Cannabigerol Market Research Report 2026
The global Cannabigerol market was valued at US$ 164 million in 2025 and is anticipated to reach US$ 292 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 147
USD 2900.00
(Single User License)
Cannabigerol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cannabigerol was estimated to be worth US$ 164 million in 2025 and is projected to reach US$ 292 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 144
USD 3950.00
(Single User License)
Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 157 million in 2024 to US$ 271 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-01
Pages: 179
USD 4900.00
(Single User License)
Global Cannabigerol Market Insights, Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 271 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published Date: 2025-06-28
Pages: 180
USD 4900.00
(Single User License)
Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cannabigerol market size was US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 108
USD 4250.00
(Single User License)
Cannabigerol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cannabigerol was estimated to be worth US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-28
Pages: 146
USD 3950.00
(Single User License)
Global Cannabigerol Market Research Report 2025
The global market for Cannabigerol was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 271 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-06-28
Pages: 107
USD 2900.00
(Single User License)
Global Cannabigerol Market Insights, Forecast to 2030
The global Cannabigerol market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-11-12
Pages: 176
USD 4900.00
(Single User License)
Global and United States Cannabigerol Market Report & Forecast 2024-2030
The global Cannabigerol revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-11-12
Pages: 144
USD 4350.00
(Single User License)
Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cannabigerol market size was US$ 164 million in 2025 and is forecast to reach a readjusted size of US$ 292 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published: 2026-03-25
Pages: 107
USD 4250.00 (Single User License)Global Cannabigerol Market Research Report 2026
The global Cannabigerol market was valued at US$ 164 million in 2025 and is anticipated to reach US$ 292 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 147
USD 2900.00 (Single User License)Cannabigerol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cannabigerol was estimated to be worth US$ 164 million in 2025 and is projected to reach US$ 292 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 144
USD 3950.00 (Single User License)Global Cannabigerol Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 157 million in 2024 to US$ 271 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-01
Pages: 179
USD 4900.00 (Single User License)Global Cannabigerol Market Insights, Forecast to 2031
The global Cannabigerol market is projected to grow from US$ 164 million in 2025 to US$ 271 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published: 2025-06-28
Pages: 180
USD 4900.00 (Single User License)Global Cannabigerol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cannabigerol market size was US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 108
USD 4250.00 (Single User License)Cannabigerol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cannabigerol was estimated to be worth US$ 157 million in 2024 and is forecast to a readjusted size of US$ 271 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-28
Pages: 146
USD 3950.00 (Single User License)Global Cannabigerol Market Research Report 2025
The global market for Cannabigerol was valued at US$ 157 million in the year 2024 and is projected to reach a revised size of US$ 271 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-06-28
Pages: 107
USD 2900.00 (Single User License)Global Cannabigerol Market Insights, Forecast to 2030
The global Cannabigerol market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-11-12
Pages: 176
USD 4900.00 (Single User License)Global and United States Cannabigerol Market Report & Forecast 2024-2030
The global Cannabigerol revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-11-12
Pages: 144
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now